Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Franklin Genomic Advancements ETF

HELX
Current price
32.97 USD -0.051 USD (-0.15%)
Company
ISIN US35473P5200
Category Healthcare
Exchange BATS
Capitalization 9 913 636 USD
Yield for 12 month +16.62 %
1Y
3Y
5Y
10Y
15Y
HELX
21.11.2021 - 28.11.2021

Franklin Genomic Advancements ETF, a constituent of the ETF, is listed on the BATS. Its market capitalization stands at 9 913 636 USD. Over the past year, it has generated a yield of +16.62 %. The fund's net expense ratio, a critical measure of operational efficiency, is recorded at 0.5 %. A significant allocation in cash assets underscores its liquidity position and risk management strategy. Turning to technical indicators, they offer a granular perspective on the fund's market behavior, historical trends, and potential forward momentum. For an in-depth analysis get premium access.

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

Total Assets

9 913 636 USD

Net Expense Ratio

0.5 %

Annual Holdings Turnover

32.63 %

Asset HoldingHELX

Cash

Long 0.64%
Short -
Net Assets 0.64%

The US stocks

Long 86.92%
Short -
Net Assets 86.92%

Stocks ex-US

Long 12.44%
Short -
Net Assets 12.44%

Bonds

Long -
Short -
Net Assets -

Other

Long -
Short -
Net Assets -

Efficiency HELX

1y Volatility 23.83%
Returns YTD 8.49%
3y Volatility 22.96%
Returns 1Y 10.78%
3y ExpReturn 0.00%
Returns 3Y -15.96%
3y SharpRatio -0.80%
Returns 5Y 0.00%
Returns 10Y 0.00%

Dividend Analytics HELX

Dividend growth over 5 years

Continuous growth

Dividend History HELX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Technical indicators HELX

For 52 weeks

25.26 USD 33.98 USD
50 Day MA 32.84 USD
200 Day MA 31.47 USD